Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,110,605

« Back to Dashboard

Summary for Patent: 5,110,605

Title: Calcium polycarbophil-alginate controlled release composition and method
Abstract:A polymeric complex composition comprising a reaction complex formed by the interaction of a polycarbophil component with alginic acid or a salt thereof, said interaction being performed in the presence of a divalent cation and in the presence of an active agent selected from the group consisting of medicinal agents and cosmetic agents. There is also described a method of controlled release treatment comprising the steps of providing such a polymeric complex and an effective amount of an active agent selected from the group consisting of medicinal agents and cosmetic agents contained within said complex, and contacting an area of skin or mucous membrane to be treated with said composition for a sufficient period of time allow a therapeutically effective amount of said active agent to be released from the complex.
Inventor(s): Acharya; Ramesh N. (Lake Forest, IL)
Assignee: Oramed, Inc. (Mundelein, IL)
Application Number:07/570,340
Patent Claim Types:
see list of patent claims
Composition; Use;

No matches for this query

International Patent Family for Patent: 5,110,605

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria137404► Subscribe
Australia8444291► Subscribe
Germany69119217► Subscribe
Denmark0497956► Subscribe
European Patent Office0497956► Subscribe
Spain2088500► Subscribe
Greece3020502► Subscribe
Japan3064417► Subscribe
JapanH05502894► Subscribe
World Intellectual Property Organization (WIPO)9203124► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: